Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Biocept, Inc.

NASDAQ: BIOCHealthcare / Medical Laboratories & Research / USA
1.0200.00Vol 660 6711Y Perf -86.27%
Apr 18th, 2019 16:00
BID1.02 ASK1.03
Open1.01 Previous Close1.02
Pre-Market1.02 After-Trading1.02
 - -%  - -%
Target Price
4.42 
Analyst Rating
Strong Buy 1.50
Potencial %
333.33 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★     44.85
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)19 
Earnings Rating
Buy
Price Range Ratio 52wk %
3.13 
Earnings Date
21st May 2019

Today's Price Range

1.011.05

 

52wk Range

0.660012.15

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Month
-6.42%
3 Months
-55.46%
6 Months
-54.87%
1 Year
-86.27%
3 Years
-99.18%
5 Years
-99.77%

Name / TickerPriceChg.Chg.%
BIOC1.020.00000.00
AAPL203.860.73000.36
GOOG1 236.370.03000.00
MSFT123.371.60001.31
XOM81.13-0.3000-0.37
WFC47.580.03000.06
JNJ137.52-1.0000-0.72
FB178.28-0.5000-0.28
GE9.350.23002.52
JPM113.46-0.8400-0.73
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
1.10
Current Ratio
1.30
Long Term Debt to Total Capital
0.24
Total Debt to Equity
0.53
Interest Coverage
-165.00
Leverage Ratio 3.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-209.30
EBIT Margin
-746.40
EBITDA Margin
-721.70
Pre-tax Profit Margin
-3 273.30
Profit Margin
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
2 443
Revenue per Share
0.13
Revenue Growth 3 Years
67.20
Revenue Growth 5 Years
127.53

Earnings HistoryEstimateReportedSurprise %
Q04 2018-1.50-1.434.67
Q03 2018-1.71-2.42-41.52
Q02 2018-3.30-2.7018.18
Q01 2018-2.10-3.30-57.14
Q04 2017-5.71-5.415.25
Q03 2017-5.71-6.01-5.25
Q02 2017-6.01-6.31-4.99
Q01 2017-6.61-6.314.54
Earnings Per EndEstimateRevision %Trend
12/2018 QR-1.50-22.95Negative
12/2018 QR-1.2218.67Positive
12/2019 FY-3.8410.28Positive
12/2019 FY-3.8410.28Positive
Next Report Date21st May 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume660 671
Shares Outstanding (in ths.)18 817
Trades Count620
Dollar Volume586 650
Avg. Volume2 851 116
Avg. Weekly Volume655 207
Avg. Monthly Volume2 720 682
Avg. Quarterly Volume2 529 457

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

31%69%

Bearish Bullish

60%40%

Bearish Bullish

55%45%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News